U.S. markets closed
  • S&P Futures

    4,250.75
    +5.00 (+0.12%)
     
  • Dow Futures

    34,494.00
    +32.00 (+0.09%)
     
  • Nasdaq Futures

    14,024.50
    +30.25 (+0.22%)
     
  • Russell 2000 Futures

    2,333.50
    +3.00 (+0.13%)
     
  • Crude Oil

    71.18
    +0.27 (+0.38%)
     
  • Gold

    1,868.10
    -11.50 (-0.61%)
     
  • Silver

    27.92
    -0.23 (-0.80%)
     
  • EUR/USD

    1.2107
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • Vix

    15.65
    -0.45 (-2.80%)
     
  • GBP/USD

    1.4116
    -0.0001 (-0.01%)
     
  • USD/JPY

    109.7340
    +0.0990 (+0.09%)
     
  • BTC-USD

    38,910.32
    +3,290.23 (+9.24%)
     
  • CMC Crypto 200

    975.47
    +33.65 (+3.57%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    29,104.00
    +155.27 (+0.54%)
     

Why Syndax Pharmaceuticals Stock Is Sinking Today

·2 min read
Why Syndax Pharmaceuticals Stock Is Sinking Today
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Syndax Pharmaceuticals (NASDAQ: SNDX) were sinking 28% as of 11:32 a.m. EDT on Tuesday. This big decline came after the company reported positive results from a phase 1 study evaluating SNDX-5613 in treating leukemia. The company reported a 48% overall response rate in patients with mixed lineage leukemia-rearranged (MLLr) and nucleophosmin (NPM1c) mutant relapsed/refractory (R/R) acute leukemias.